
Objective
This annual conference will bring legal practitioners working with the pharmaceutical sector up-to-date on the latest relevant regulatory developments, legislative initiatives and case law.
Key topics
Competition law in the pharmaceutical sector
- Mergers
 - Alleged excessive pricing
 
Patent law in the pharmaceutical sector and other intellectual property incentives on innovation
- Recent CJEU rulings on supplementary protection certificates (SPCs)
 - First results of the European Commission’s public consultation on pharmaceutical incentives and the way forward
 
EU pharmaceutical law round-up
- Access to data and new digital initiatives on big data in public health
 - Recent activities of the European Commission and the EMA
 - Off-label use in Europe
 - Advanced therapy medicinal products
 
				Click here to view the full conference programme. | 
		
Who should attend?
In-house counsel and legal or patent advisers in pharmaceutical companies; lawyers in private practice dealing with pharmaceuticals and medical devices; lawyers in national ministries and authorities dealing with regulation of the sector.
You will learn…
- How are competition law cases before the Commission affecting the pharmaceutical sector?
 - What can be learnt from the implementation of the EMA policy on the publication of clinical data?
 - How can big data bring new challenges and opportunities for the health and pharmaceutical sectors?
 - Should the EU legal framework on intellectual property incentives for innovation be changed?
 - How is off-label use regulated in the European Union?
 - How far are recent rulings of the CJEU and new EU proposals affecting the pharmaceutical sector?
 
Evening networking reception
On Thursday 1 March, you will have the chance to network with colleagues at our drinks reception.
Speakers
- Simone Boselli, Public Affairs Director, EURORDIS, Brussels
 - Alfonso Calles-Sanchez, Legal and Policy Affairs Officer, Intellectual Property and Fight Against Counterfeiting, DG GROW, European Commission, Brussels
 - Nicola Dagg, Partner, Allen & Overy, London
 - Brian Kelly, Partner, Covington & Burling, London
 - John Lisman, Lisman Legal Life Sciences B.V., Heijen
 - Catherine Longeval, Partner, Van Bael & Bellis, Brussels
 - Geneviève Michaux , Partner, Mayer Brown, Brussels
 - Alexander Natz, Secretary General, EUCOPE, Brussels
 - Kristine Peers, General Counsel, Legal Affairs, EFPIA, Brussels
 - Rositsa Pencheva, Case Handler, DG Competition, European Commission, Brussels
 - Peter Picht, Chair of Business and Commercial Law, Centre for Intellectual Property and Competition Law, University
 - of Zurich
 - Tapani Piha, Head of Unit, Cross-Border Healthcare and eHealth, DG Health & Food Safety, European Commission, Brussels
 - Aleksandar Rusanov, Legal Administrator, European Medicines Agency, London
 - Bart Van Vooren, Associate, Covington & Burling, Brussels
 
CPD: ERA’s programmes meet the standard requirements for recognition as Continuing Professional Development (CPD). This event corresponds to 10 CPD hours.












